RevMed - RVMD Revenue Growth QoQ

Graphic logo of Revolution Medicines Corp (RVMD)

The costly cold chain supply of chemical compounds impacts the credit profile of Revolution Medicines (RVMD). The quarterly revenue growth rate reflects current price action, where the value of 0.00 determines this level. A lack of sales and high R&D expenses render cash flows unpredictable; however, inelastic demand for oncology therapies ensures business resilience regardless of economic cycles.

RVMD Revolution Medicines Corp Revenue Growth QoQ (07/04/2022 - 11/20/2026)

Revolution Medicines, Inc. (RVMD) - metric breakdowns and financial figures

- share price and expert price forecast:
- cash and cash movement details:
Fundamental company analysis:RVMD - Revolution Medicines Inc
Flagship merchandise of revmed.com

The quarterly revenue growth rate measures the percentage change in income between the current and previous quarters, allowing for an assessment of business scaling dynamics and the effectiveness of innovation commercialization. An analysis of the quarterly revenue change for Revolution Medicines (RVMD) demonstrates how automated drug synthesis and AI modeling are accelerating financial growth despite lengthy clinical trials, confirming the overall resilience of the business model.

Main competitors

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|AAPG: Quarterly Revenue Growth|Quarterly Revenue Growth Rate CG Oncology Inc (CGON)|URGN (urogen.com) - Quarterly Revenue Growth|BCAX: Quarterly Revenue Increase|Revenue Growth QoQ Personalis (PSNL)|Quarterly Revenue Growth Erasca (ERAS)|Quarterly Revenue Growth DCTH (Delcath Systems)|Quarterly Revenue Increase YMAB|AURA - Revenue Growth QoQ|candeltx.com - Sales Change QoQ|ARAY: Quarterly Revenue Growth|Revenue Dynamics QoQ SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Quarterly Revenue Growth|Quarterly Sales Growth Citius Oncology Inc. (CTOR)|Revenue Growth QoQ TuHURA (HURA)|TARA - Quarterly Revenue Growth Rate|Quarterly Revenue Growth FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Quarterly Revenue Growth Rate|TScan - Quarterly Revenue Growth|Champions Oncology, Inc. (CSBR) - Quarterly Sales Growth|XBIT (XBiotech Inc.) - Quarterly Sales Growth|CEL-SCI Corporation (CVM) - Quarterly Revenue Growth|Revenue Growth QoQ OS Therapies|RADX: Quarterly Revenue Increase|Revenue Growth QoQ artivabio.com (ARTV)|Quarterly Sales Growth Rate Adlai Nortye|Quarterly Revenue Growth VERU (Veru Corporation)|Sales Change QoQ TPST (Tempest Tx)|XLO: Quarterly Sales Growth|renovarobio.com (RENB) - Quarterly Sales Growth|Mural Bio (MURA) - Revenue Growth QoQ|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)